Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKBA | ZTS | TAK | UTHR | NBIX |
| Company | Akebia Therapeutics | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 1.3500 | 180.04 | 13.40 | 328.91 | 144.47 |
| High | 1.3700 | 180.51 | 13.42 | 331.73 | 146.30 |
| Low | 1.3000 | 176.17 | 13.24 | 326.49 | 143.09 |
| Last | 1.3500 | 178.58 | 13.36 | 329.16 | 145.69 |
| Change | -0.0100 | -0.65 | -0.13 | +0.49 | +1.55 |
| % Change | -0.74% | -0.36% | -0.96% | +0.15% | +1.08% |
| Volume | 1,881,900 | 2,131,400 | 4,167,400 | 300,400 | 600,000 |
| 20-Day Average Volume | 4,606,875 | 2,317,990 | 1,781,010 | 576,010 | 789,220 |
| Previous Close | 1.3600 | 179.23 | 13.49 | 328.67 | 144.14 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.0913 | 175.51 | 13.16 | 321.44 | 141.10 |
| 20-Day Raw Stochastic | 83.33% | 65.96% | 66.09% | 66.96% | 73.55% |
| 20-Day Relative Strength | 61.46% | 55.87% | 52.68% | 70.41% | 58.84% |
| Weighted Alpha | -18.73 | -1.30 | -13.16 | +49.08 | +43.40 |
| Today's Opinion | 8% Sell | 40% Buy | 56% Sell | 100% Buy | 100% Buy |
| Previous Opinion | 8% Sell | 40% Buy | 56% Sell | 100% Buy | 100% Buy |
| Last Month's Opinion | 88% Sell | 64% Sell | 96% Sell | 100% Buy | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.14% since 07/12/24 | -0.26% since 07/12/24 | -0.60% since 07/12/24 | +2.42% since 07/12/24 | -1.18% since 07/12/24 |
| Low | 1.2400 on 07/15/24 | 176.17 on 07/19/24 | 13.24 on 07/19/24 | 321.87 on 07/15/24 | 143.09 on 07/19/24 |
| High | 1.4600 on 07/16/24 | 184.84 on 07/17/24 | 13.75 on 07/17/24 | 339.56 on 07/17/24 | 150.39 on 07/16/24 |
| 1-Month | |||||
| %Chg | +33.66% since 06/18/24 | +5.26% since 06/18/24 | +5.45% since 06/18/24 | +7.55% since 06/18/24 | +11.33% since 06/18/24 |
| Low | 0.8000 on 06/26/24 | 166.45 on 06/26/24 | 12.57 on 06/20/24 | 302.71 on 06/20/24 | 129.33 on 06/20/24 |
| High | 1.4600 on 07/16/24 | 184.84 on 07/17/24 | 13.75 on 07/17/24 | 339.56 on 07/17/24 | 150.39 on 07/16/24 |
| 3-Month | |||||
| %Chg | -0.74% since 04/19/24 | +21.90% since 04/19/24 | +0.91% since 04/19/24 | +38.34% since 04/19/24 | +10.37% since 04/19/24 |
| Low | 0.8000 on 06/26/24 | 144.80 on 04/22/24 | 12.57 on 06/20/24 | 233.27 on 04/24/24 | 129.33 on 06/20/24 |
| High | 1.5600 on 05/07/24 | 184.84 on 07/17/24 | 13.75 on 07/17/24 | 339.56 on 07/17/24 | 150.39 on 07/16/24 |
| 6-Month | |||||
| %Chg | -3.57% since 01/19/24 | -5.20% since 01/19/24 | -9.18% since 01/19/24 | +51.10% since 01/19/24 | +6.06% since 01/19/24 |
| Low | 0.8000 on 06/26/24 | 144.80 on 04/22/24 | 12.57 on 06/20/24 | 208.62 on 02/08/24 | 128.00 on 02/07/24 |
| High | 2.4800 on 03/28/24 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 339.56 on 07/17/24 | 150.39 on 07/16/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 282,955 | 81,485,168 | 42,282,220 | 14,600,219 | 14,661,805 |
| Shares Outstanding, K | 209,596 | 456,295 | 3,164,837 | 44,356 | 100,637 |
| Annual Sales | 194,620,000 | 8,544,000,000 | 29,419,960,000 | 2,327,500,000 | 1,887,100,000 |
| Annual Net Income | -51,930,000 | 2,344,000,000 | 994,060,000 | 984,800,000 | 249,700,000 |
| Last Quarter Sales | 32,610,000 | 2,190,000,000 | 6,938,670,000 | 677,700,000 | 515,300,000 |
| Last Quarter Net Income | -17,990,000 | 599,000,000 | -46,010,000 | 306,600,000 | 43,400,000 |
| 60-Month Beta | 0.77 | 0.86 | 0.54 | 0.55 | 0.37 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.09 on 05/09/24 | 1.38 on 05/02/24 | 0.00 on 05/09/24 | 6.17 on 05/01/24 | 0.42 on 05/01/24 |
| Latest Earnings Date | 08/23/24 | 08/06/24 | 07/31/24 | 08/07/24 | 08/01/24 |
| Most Recent Dividend | N/A | 0.432 on 07/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 07/18/24 | 03/27/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 33.25 | 8.65 | 15.54 | 39.71 |